Medical News

RSS

Tel Aviv University psychologist busts myth and offers tips to counter mid-life crisis

Elliot Jacques coined the term "mid-life crisis" 40 years ago, when the average lifespan was 70 and "mid-life" came at age 35. Individuals could expect their quality of life to decline from that point forward, Jacques argued, so some extreme reactions to encroaching mortality were to be expected, such as having extra-marital affairs and buying a Corvette.

22 Jan 2010

Wars less deadly, most war-related deaths result from disease, hunger, report says

"Wars are less deadly than they once were and national mortality rates have continued to decline even during conflicts due to smaller scale fighting and better healthcare," according to a study released Wednesday by the Human Security Report Project, Reuters reports. "The report noted that most deaths in wars result from hunger and disease but said improved healthcare in peacetime had cut death tolls even during wartime, as had stepped up aid to people in war zones," according to the news service.

21 Jan 2010

UCLB, Kurma Biofund form partnership

UCLB is delighted to announce a partnership with Kurma Biofund, a recently formed venture capital fund based in Paris and dedicated to innovations in life sciences and healthcare. Kurma recently announced the closing of a first round of financing totalling -50 million.

21 Jan 2010

Reducing dietary salt can offer significant health benefits

Reducing salt in the American diet by as little as one-half teaspoon (or three grams) per day could prevent nearly 100,000 heart attacks and 92,000 deaths each year, according to a new study. Such benefits are on par with the benefits from reductions in smoking and could save the United States about $24 billion in healthcare costs, the researchers add.

21 Jan 2010

Genzyme receives PDUFA date from FDA for its Biologics License Application for Lumizyme

Genzyme Corporation announced today that it has received a June 17, 2010 PDUFA date from the FDA for its Biologics License Application for Lumizyme™ (alglucosidase alfa) seeking approval for the therapy produced at the 4000 L scale.

21 Jan 2010

VNSNY receives funding for testing IT strategies to aid elderly cognitive impairment patients

The Visiting Nurse Service of New York (VNSNY) Center for Home Health Care Policy & Research, the only research center focused on studying home health care in the U.S., has received funding from The Center for Technology and Aging to test state-of-the art information technology (IT) strategies designed to help elderly patients with cognitive impairment and their caregivers safely manage multiple medications.

21 Jan 2010

Behavioral Innovations opens its first autism treatment center in Texas

Behavioral Innovations, the premier provider of Applied Behavior Analysis (ABA) services for families of children with autism and other developmental disorders, today announces the opening of its San Antonio location, which will begin offering services February 1. The company is in the process of expanding to Fort Worth and Wichita Falls where they will begin serving families in early spring.

21 Jan 2010

Gamma Pharmaceuticals signs Distribution Agreement for its branded product ranges

Gamma Pharmaceuticals Inc. announced today that the Company has signed a Distribution Agreement for Gamma's branded product ranges. Under the Distribution Agreement, Gamma's monthly sales will ramp-up to $3.4 million.

21 Jan 2010

Cancer Research UK offers translation service for people affected by cancer

Thanks to a partnership with Language Line - who interpret telephone conversations in over 170 languages - people affected by cancer who need an interpreter can now have their questions answered.

21 Jan 2010

FDA approves continuous-flow heart-assist device pioneered at Texas Heart Institute at SLEH

The federal Food and Drug Administration today approved a continuous-flow heart-assist device pioneered at the Texas Heart Institute (THI) at St. Luke’s Episcopal Hospital (SLEH) for use as a permanent treatment for advanced heart failure.

21 Jan 2010

Scientific/technical review for XIAFLEX' European MAA commences

BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that its partner Auxilium Pharmaceuticals, Inc. announced that Pfizer Inc. received notification from the European Medicines Agency that the Marketing and Authorization Application (MAA) for XIAFLEX™ for the treatment of Dupuytren's disease (a debilitating disorder resulting from excessive collagen deposition that causes contractures of the fingers) has completed the validation phase successfully and that the scientific/technical review procedure commenced today.

21 Jan 2010

Five questions for successful weight loss

The American Society of Bariatric Physicians (ASBP) works with physicians so they’re better prepared to deal with society’s obesity epidemic. Even though people focus on weight loss more in January than any other month, successful weight loss is a year-round long-term initiative that goes far beyond just diet and exercise. The ASBP has highlighted five questions everyone who needs to lose weight should ask their physician.

21 Jan 2010

Celerus Diagnostics demonstrates Rapid ISH on its Wave RPD System

Through collaborative efforts with multiple industry partners, Celerus Diagnostics has successfully demonstrated Rapid ISH™ (in-situ hybridization) on its forthcoming Wave RPD System.

21 Jan 2010

Republican leaders: Dems aren't reaching out to pass health reform bill

The Christian Science Monitor: Even after the GOP win in Massachusetts that cost Democrats their "filibuster-proof margin in the Senate," congressional Republican leaders say Democrats don't appear to want to work with them on a health care plan that could clear Congress, according to The Monitor Breakfast.

21 Jan 2010

Teva Pharmaceutical Industries receives FDA tentative approval for generic Femara Tablets

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Novartis’ breast cancer treatment Femara® (letrozole) Tablets, 2.5 mg. Final approval of Teva’s Letrozole Tablets is expected upon expiry of patent protection for the brand product in June 2011.

21 Jan 2010

University of Miami psychologists use non-expert student observers in autism research

Non-expert is not often a term that one would associate with scientific research, but it could become a new trend in psychology research. Some recent studies have begun to rely on non-expert students to observe and provide data during experiments.

21 Jan 2010

BMEYE ccNexfin and Masimo Rainbow SET Pulse CO-Oximetry technology receive CE Mark certification

BMEYE B.V., the innovators of combined noninvasive, beat-to-beat blood pressure and cardiac output monitoring, and Masimo, the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low-Perfusion pulse oximetry, jointly announce today CE Mark certification and the European launch of the BMEYE ccNexfin—the first noninvasive cardiovascular monitor with Masimo Rainbow SET Pulse CO-Oximetry technology

21 Jan 2010

Pelosi: Senate health bill won't pass the House without changes

Reuters: "U.S. House of Representatives Speaker Nancy Pelosi said on Thursday she does not think the Senate's version of healthcare reform has enough support in the House to pass without changes." She said she didn't see the votes for it, adding that Democratic congressional leaders were "not in a big rush" to figure out the next move on healthcare, but that they are committed to passing a bill this year (Smith, 1/21).

21 Jan 2010

Data demonstrates overall radiation with digital mammography is less than film mammography

Data from one of the largest mammography trials in history demonstrates that overall the radiation dose associated with digital mammography is significantly lower (averaging 22 percent lower) than that of conventional film mammography and that the reduction could be greater in women with larger and denser breasts, according to a study published in the February issue of the American Journal of Roentgenology.

21 Jan 2010

AMA, AARP and MOAA join in unprecedented multi-state event to focus on Medicare physician cuts

Focusing on looming Medicare physician cuts of 21 percent that begin on March 1, the American Medical Association (AMA), AARP and the Military Officers Association of America (MOAA) joined together today in an unprecedented multi-state event.

21 Jan 2010

Medical News

Tel Aviv University psychologist busts myth and offers tips to counter mid-life crisis

Wars less deadly, most war-related deaths result from disease, hunger, report says

UCLB, Kurma Biofund form partnership

Reducing dietary salt can offer significant health benefits

Genzyme receives PDUFA date from FDA for its Biologics License Application for Lumizyme

VNSNY receives funding for testing IT strategies to aid elderly cognitive impairment patients

Behavioral Innovations opens its first autism treatment center in Texas

Gamma Pharmaceuticals signs Distribution Agreement for its branded product ranges

Cancer Research UK offers translation service for people affected by cancer

FDA approves continuous-flow heart-assist device pioneered at Texas Heart Institute at SLEH

Scientific/technical review for XIAFLEX' European MAA commences

Five questions for successful weight loss

Celerus Diagnostics demonstrates Rapid ISH on its Wave RPD System

Republican leaders: Dems aren't reaching out to pass health reform bill

Teva Pharmaceutical Industries receives FDA tentative approval for generic Femara Tablets

University of Miami psychologists use non-expert student observers in autism research

BMEYE ccNexfin and Masimo Rainbow SET Pulse CO-Oximetry technology receive CE Mark certification

Pelosi: Senate health bill won't pass the House without changes

Data demonstrates overall radiation with digital mammography is less than film mammography

AMA, AARP and MOAA join in unprecedented multi-state event to focus on Medicare physician cuts

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News